Sr Manager Market Access at Eli Lilly and Company

Toronto, Ontario, Canada

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Bachelor’s degree or higher required, ideally in a scientific field
Significant pharmaceutical industry experience
Minimum 5 years of experience in market access and/or related functions (e.g. HEOR)
In-depth knowledge of CDA-AMC, INESSS, pCPA and Product Listing Agreements processes
Strong Commercial/business background an asset
Ability to work well cross-functionally
Outstanding strategic thinking skills—proven ability to identify/define business questions and issues, synthesize information from multiple sources, conduct analysis, formulate actionable recommendations
High-energy, self-starter that is assertive, possesses a high degree of self-confidence and intellectual curiosity, exhibits a bias for action and demonstrates good executive presence
Energized by working with ambiguity and complexity
Ability to think creatively in developing and implementing business solutions
High degree of initiative and sense of urgency

Responsibilities

Lead the development and delivery of market access strategies, including pre-launch planning, portfolio assessment and CDA-AMC/INESSS, provincial and private payer submissions
Oversee cross-functional development and execution of payer solutions and evidence generation to support reimbursement objectives
Develop business cases in partnership with Pricing / Commercial / Finance teams to communicate strategies and approve prices with local and global leadership
In collaboration with Pricing and Regional Market Access Team, support the development of pCPA negotiation strategies
Develop value dossiers for national and regional Health Technology Assessment (HTA) bodies and payers (public and private)
Lead the planning and development of sound health economic arguments, including robust pharmacoeconomic modeling and budget impact analyses
Operate as a key member of the commercial core teams and be a role model for cross-functional working to ensure therapeutic area objectives are met
Cultivate partnerships with the global organization to understand and support the market access needs of the business in Canada

Skills

Market Access

Pricing Strategy

Reimbursement Strategy

Health Technology Assessment

HTA

Payer Contracting

Value Proposition

Value Dossier

Business Case Development

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free